AdvaMed's CEO on New Payment Models, Repealing Device Tax
Saturday, October 25, 2014
Source: Modern Healthcare
Stephen Ubl became president and CEO in 2005 of the Advanced Medical Technology Association, a 270-member group representing manufacturers of medical devices, diagnostic products and medical information systems. Ubl joined AdvaMed in 1998 as executive vice president of federal government relations. He previously served as vice president of legislation for the Federation of American Hospitals and worked as an aide to Sen. Chuck Grassley (R-Iowa). As a lobbyist, Ubl has led efforts to change the Food and Drug Administration product-review process and Medicare's coverage and reimbursement of medical technologies. Modern Healthcare reporter Sabriya Rice recently spoke with Ubl about the potential impact of new payment models, as well as regulatory and tax issues, on the $110 billion device industry. This is an edited transcript.